Fig. 2From: Supporting patients in the transition to the revised pexidartinib dosing regimen: perspectives from the multidisciplinary clinical and allied health professional teamChanges in pexidartinib exposure after a high-fat or low-fat meal compared to the fasted state. LFM, low-fat meal. aLamb YN. Pexidartinib: first approval. Drugs. 2019;79(16):1805–1812. bTURALIO® (pexidartinib) capsules [package insert]. Basking Ridge, NJ: Daiichi Sankyo, Inc.; October 2022Back to article page